Proteomics analysis reveals the mechanism of anemoside B4 in treating clinical mastitis in dairy cows
(1) Background: The therapeutic efficacy of AB4 in cows with CM is well-established, but the specific mechanism remains to be explored. This study was based on Label free relative quantitative proteomics technology to reveal the internal mechanism of AB4 treatment of CM; (2) Methods: Twelve healthy...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Italian Journal of Animal Science |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/1828051X.2024.2441345 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846095108102946816 |
|---|---|
| author | Zeru Zhang Yuquan Zhao Zhetong Su Ke Dong Zhicai Zuo Yixin Huang Shumin Yu Suizhong Cao Liuhong Shen |
| author_facet | Zeru Zhang Yuquan Zhao Zhetong Su Ke Dong Zhicai Zuo Yixin Huang Shumin Yu Suizhong Cao Liuhong Shen |
| author_sort | Zeru Zhang |
| collection | DOAJ |
| description | (1) Background: The therapeutic efficacy of AB4 in cows with CM is well-established, but the specific mechanism remains to be explored. This study was based on Label free relative quantitative proteomics technology to reveal the internal mechanism of AB4 treatment of CM; (2) Methods: Twelve healthy Chinese Holstein cows (group C) and twelve Chinese Holstein cows (group T) with CM were selected. Administer 30 mL of AB4 via intramuscular injection to cows with CM once per day, for 7 consecutive days. The tail venous blood of group C on any day and group T before medication on day 1 (designated as T1) and after medication on day 7 (designated as T2) were collected. Randomly divide the samples from each of the three groups into three subgroups (three biological replicates, with each replicate consisting of an equal mixture of four plasma samples). They are labelled C1, C2, C3 and T1-1, T1-2, T1-3, T2-1, T2-2, T2-3. The differential proteins of AB4 in the treatment of CM were screened and bioinformatic analysis was performed; (3) Results: AB4 could regulate the levels of HSPs and other proteins, participate in chemokine signal transduction, leukocyte migration across endothelial cells, MAPKs pathway and other pathways to improve the inflammatory response of the body. In addition, the cured cows showed significantly higher complement lev-els, b-defensin 12 levels, and the ability to regulate lipid metabolism compared to diseased and healthy cows, suggesting that AB4 can directly activate C2, triggering downstream responses to activate the complement system, while stimulating defensins secretion and regulating lipid metabolism. |
| format | Article |
| id | doaj-art-90b362b22e874cd1bce8d3ffef61b29e |
| institution | Kabale University |
| issn | 1594-4077 1828-051X |
| language | English |
| publishDate | 2025-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Italian Journal of Animal Science |
| spelling | doaj-art-90b362b22e874cd1bce8d3ffef61b29e2025-01-02T11:34:22ZengTaylor & Francis GroupItalian Journal of Animal Science1594-40771828-051X2025-12-01241788810.1080/1828051X.2024.24413452441345Proteomics analysis reveals the mechanism of anemoside B4 in treating clinical mastitis in dairy cowsZeru Zhang0Yuquan Zhao1Zhetong Su2Ke Dong3Zhicai Zuo4Yixin Huang5Shumin Yu6Suizhong Cao7Liuhong Shen8The Key Laboratory of Animal Disease and Human Health of Sichuan Province, The Medical Research Center for Cow Disease, College of Veterinary Medicine, Sichuan Agricultural UniversityThe Key Laboratory of Animal Disease and Human Health of Sichuan Province, The Medical Research Center for Cow Disease, College of Veterinary Medicine, Sichuan Agricultural UniversityResearch and Development Center, Guangxi Innovates Medical Technology Co., LtdResearch and Development Center, Sichuan Yuqiang Materia Medica Biotechnology Co., LtdThe Key Laboratory of Animal Disease and Human Health of Sichuan Province, The Medical Research Center for Cow Disease, College of Veterinary Medicine, Sichuan Agricultural UniversityThe Key Laboratory of Animal Disease and Human Health of Sichuan Province, The Medical Research Center for Cow Disease, College of Veterinary Medicine, Sichuan Agricultural UniversityThe Key Laboratory of Animal Disease and Human Health of Sichuan Province, The Medical Research Center for Cow Disease, College of Veterinary Medicine, Sichuan Agricultural UniversityThe Key Laboratory of Animal Disease and Human Health of Sichuan Province, The Medical Research Center for Cow Disease, College of Veterinary Medicine, Sichuan Agricultural UniversityThe Key Laboratory of Animal Disease and Human Health of Sichuan Province, The Medical Research Center for Cow Disease, College of Veterinary Medicine, Sichuan Agricultural University(1) Background: The therapeutic efficacy of AB4 in cows with CM is well-established, but the specific mechanism remains to be explored. This study was based on Label free relative quantitative proteomics technology to reveal the internal mechanism of AB4 treatment of CM; (2) Methods: Twelve healthy Chinese Holstein cows (group C) and twelve Chinese Holstein cows (group T) with CM were selected. Administer 30 mL of AB4 via intramuscular injection to cows with CM once per day, for 7 consecutive days. The tail venous blood of group C on any day and group T before medication on day 1 (designated as T1) and after medication on day 7 (designated as T2) were collected. Randomly divide the samples from each of the three groups into three subgroups (three biological replicates, with each replicate consisting of an equal mixture of four plasma samples). They are labelled C1, C2, C3 and T1-1, T1-2, T1-3, T2-1, T2-2, T2-3. The differential proteins of AB4 in the treatment of CM were screened and bioinformatic analysis was performed; (3) Results: AB4 could regulate the levels of HSPs and other proteins, participate in chemokine signal transduction, leukocyte migration across endothelial cells, MAPKs pathway and other pathways to improve the inflammatory response of the body. In addition, the cured cows showed significantly higher complement lev-els, b-defensin 12 levels, and the ability to regulate lipid metabolism compared to diseased and healthy cows, suggesting that AB4 can directly activate C2, triggering downstream responses to activate the complement system, while stimulating defensins secretion and regulating lipid metabolism.http://dx.doi.org/10.1080/1828051X.2024.2441345anemoside b4clinical mastitiscowsproteomics |
| spellingShingle | Zeru Zhang Yuquan Zhao Zhetong Su Ke Dong Zhicai Zuo Yixin Huang Shumin Yu Suizhong Cao Liuhong Shen Proteomics analysis reveals the mechanism of anemoside B4 in treating clinical mastitis in dairy cows Italian Journal of Animal Science anemoside b4 clinical mastitis cows proteomics |
| title | Proteomics analysis reveals the mechanism of anemoside B4 in treating clinical mastitis in dairy cows |
| title_full | Proteomics analysis reveals the mechanism of anemoside B4 in treating clinical mastitis in dairy cows |
| title_fullStr | Proteomics analysis reveals the mechanism of anemoside B4 in treating clinical mastitis in dairy cows |
| title_full_unstemmed | Proteomics analysis reveals the mechanism of anemoside B4 in treating clinical mastitis in dairy cows |
| title_short | Proteomics analysis reveals the mechanism of anemoside B4 in treating clinical mastitis in dairy cows |
| title_sort | proteomics analysis reveals the mechanism of anemoside b4 in treating clinical mastitis in dairy cows |
| topic | anemoside b4 clinical mastitis cows proteomics |
| url | http://dx.doi.org/10.1080/1828051X.2024.2441345 |
| work_keys_str_mv | AT zeruzhang proteomicsanalysisrevealsthemechanismofanemosideb4intreatingclinicalmastitisindairycows AT yuquanzhao proteomicsanalysisrevealsthemechanismofanemosideb4intreatingclinicalmastitisindairycows AT zhetongsu proteomicsanalysisrevealsthemechanismofanemosideb4intreatingclinicalmastitisindairycows AT kedong proteomicsanalysisrevealsthemechanismofanemosideb4intreatingclinicalmastitisindairycows AT zhicaizuo proteomicsanalysisrevealsthemechanismofanemosideb4intreatingclinicalmastitisindairycows AT yixinhuang proteomicsanalysisrevealsthemechanismofanemosideb4intreatingclinicalmastitisindairycows AT shuminyu proteomicsanalysisrevealsthemechanismofanemosideb4intreatingclinicalmastitisindairycows AT suizhongcao proteomicsanalysisrevealsthemechanismofanemosideb4intreatingclinicalmastitisindairycows AT liuhongshen proteomicsanalysisrevealsthemechanismofanemosideb4intreatingclinicalmastitisindairycows |